About ILS (Integrated Laboratory Systems)
ILS (Integrated Laboratory Systems) is a Healthcare company based in Morrisville (United States) founded in 1985, and was acquired by Inotiv in January 2022. Clinical research and regulatory services are provided by ILS. It operates on a Professional Services model. ILS (Integrated Laboratory Systems) offers products and services including Toxicology Services, Discovery and Translational Sciences, and Teklad Bedding and Enrichment Products. Its focus areas include Biotechnology and Toxicology Services. Its legal entity is Inotiv.
Company details
ILS, operating under Inotiv, is focused on delivering comprehensive toxicology services to support research and regulatory compliance needs. Services are provided across various therapeutic areas including cardiovascular, oncology, and neuroscience. Solutions encompass discovery, safety assessment, and bioanalysis for both large and small molecules. Additionally, research models, genetically engineered models, and bedding products like Teklad are offered to facilitate scientific studies. The company is involved in in vivo and in vitro toxicology, pathology, and genetic toxicology, ensuring multidisciplinary support for clients in the biotechnology and pharmaceutical sectors.
- Headquarters Morrisville, United States
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website ils-inc.com
- Social LinkedIn
- Acquired by Inotiv (Jan 2022)
- Legal Name Inotiv
Products & Services of ILS (Integrated Laboratory Systems)
ILS (Integrated Laboratory Systems) offers a comprehensive portfolio of products and services, including Toxicology Services, Discovery and Translational Sciences, and Teklad Bedding and Enrichment Products.
Toxicology services are provided for research and compliance.
Support for drug discovery and translational research is offered.
Bedding and enrichment products for research are supplied.
Funding Insights of ILS (Integrated Laboratory Systems)
- Total Rounds 3
- Last Round Grant — $1.63M
- First Round $1.23M
(Aug 2012)
- Investors Count 1
All 3 funding rounds of ILS (Integrated Laboratory Systems) with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
2 investors in total: 2 institutional.
Investors in ILS (Integrated Laboratory Systems)
ILS (Integrated Laboratory Systems) has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and Inotiv Co.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Clinical development and regulatory services are provided by Inotiv. | 1974 | inotivco.com | Lafayette, United States |
Investor details for ILS (Integrated Laboratory Systems)
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of ILS (Integrated Laboratory Systems)
4 dated milestones of ILS (Integrated Laboratory Systems) across 37 years, from founding to its latest funding, stage changes and deals.
- Founded ILS (Integrated Laboratory Systems) is founded.
- Funding First funding round of $1.2M.
- Funding Latest funding round, Grant, of $1.6M.
- Exit Acquired by Inotiv.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as ILS (Integrated Laboratory Systems) (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ils (Integrated Laboratory Systems)
Complete news archive for ILS (Integrated Laboratory Systems)
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ILS (Integrated Laboratory Systems)
ILS (Integrated Laboratory Systems) was founded in 1985 and raised its 1st funding round 27 years after it was founded.
ILS (Integrated Laboratory Systems) is headquartered in Morrisville, United States.
ILS, operating under Inotiv, is focused on delivering comprehensive toxicology services to support research and regulatory compliance needs. Services are provided across various therapeutic areas including cardiovascular, oncology, and neuroscience. Solutions encompass discovery, safety assessment, and bioanalysis for both large and small molecules. Additionally, research models, genetically engineered models, and bedding products like Teklad are offered to facilitate scientific studies. The company is involved in in vivo and in vitro toxicology, pathology, and genetic toxicology, ensuring multidisciplinary support for clients in the biotechnology and pharmaceutical sectors.
ILS (Integrated Laboratory Systems) offers Toxicology Services, Discovery and Translational Sciences, and Teklad Bedding and Enrichment Products.
ILS (Integrated Laboratory Systems) operates through Inotiv.
Yes. ILS (Integrated Laboratory Systems) was acquired by Inotiv in January 2022.